Dose response test of patient-derived cancer organoids to irradiation

Haina Yu1, Canfeng Lin2, Fan Chen3

  • 1Department of Medical Oncology, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian), Quanzhou, China.

Frontiers in Oncology
|November 12, 2025
PubMed
Abstract

Insights

Patient-derived cancer organoids offer a valuable tool for radiation oncology research. Image-based analysis is a more accurate method than cell counting kit-8 for assessing cancer organoid radiosensitivity.

Area of Science:

  • Oncology
  • Radiotherapy Research
  • Cancer Biology

Background:

  • Patient-derived cancer organoids are innovative models for precision medicine.
  • Radiation oncologists need to recognize the value of organoids in radiation oncology.
  • Standardized methods for assessing organoid cell death post-irradiation are lacking.

Purpose of the Study:

  • To establish and characterize rectal cancer organoid lines.
  • To evaluate methods for assessing rectal cancer organoid radiosensitivity.
  • To determine the most accurate method for evaluating organoid survival after irradiation.

Main Methods:

  • Established three rectal cancer organoid lines from surgical specimens.
  • Performed genetic characterization of the organoid lines.
  • Assessed organoid survival after X-ray irradiation using image-based analysis and Cell Counting Kit-8.

Main Results:

  • Organoid lines reflected tumor heterogeneity and common mutations.
  • Image-based analysis accurately validated organoid survival post-irradiation.
  • Cell Counting Kit-8 failed to accurately assess survival; imaging provided more representative survival curves.

Conclusions:

  • Cancer organoids are practical for radiobiology research.
  • Image-based analysis is superior to Cell Counting Kit-8 for studying cancer organoid radiosensitivity.